|
Canada-0-TileNonCeramicDistributors ไดเรกทอรีที่ บริษัท
|
ข่าว บริษัท :
- Efficacy and safety of DaxibotulinumtoxinA for injection in adults with . . .
To evaluate the pooled efficacy and safety of DAXI for CD across two phase 3, multicenter, randomized, double-blind, placebo-controlled trials: ASPEN-1, conducted in North America and Europe, and ASPEN-1-CN, a similarly designed, smaller pivotal clinical trial, conducted in China
- Efficacy and Safety of DaxibotulinumtoxinA for Injection in Cervical . . .
ASPEN-1 was a phase 3, randomized, double-blind, placebo-controlled study to evaluate the efficacy, duration of response, and safety of 2 doses of DaxibotulinumtoxinA for Injection (DAXI), a novel botulinum toxin type A formulation in participants with cervical dystonia (CD)
- Efficacy and safety of botulinum type A toxin (Dysport) in cervical . . .
Botulinum toxin type A (Dysport) has been shown in European studies to be a safe and effective treatment for cervical dystonia This multicenter, double-blind, randomized, controlled trial assessed the safety and efficacy of Dysport in cervical dystonia patients in the United States
- Botulinum Toxin in the Treatment of Cervical Dystonia: Evidence-Based . . .
Several studies, including nearly two dozen randomized clinical trials, have shown that botulinum toxin is safe and effective in reducing the clinical severity of cervical dystonia Longitudinal data have demonstrated decades of sustained benefit and safety
- Treatment of cervical dystonia with abo- and . . . - PubMed
We show that treatment of cervical dystonia with the two most frequently used botulinum toxin A preparations is a safe and effective therapy even over a long treatment duration of up to 27 years
- Efficacy and safety of botulinum type A toxin (Dysport) in cervical . . .
Botulinum toxin type A (Dysport) has been shown in European studies to be a safe and effective treatment for cervical dystonia This multicenter, double‐blind, randomized, controlled trial assessed the safety and efficacy of Dysport in cervical dystonia patients in the United States
- Treatment with botulinum toxin type A for people with involuntary . . .
Currently, botulinum toxin type A (BtA) is considered the first line therapy for this condition To compare the efficacy, safety, and tolerability of BtA versus placebo, in people with cervical dystonia
- Efficacy and safety of botulinum type A toxin (Dysport) in cervical . . .
Botulinum toxin type A (Dysport) has been shown in European studies to be a safe and effective treatment for cervical dystonia This multicenter, double-blind, randomized, controlled trial assessed the safety and efficacy of Dysport in cervical dystonia patients in the United States
- ICH GCP - EU Clinical trials Registry - 2018-000446-19 (GB . . .
。 ICH GCP。 ICH GCP 欧盟临床试验注册处
- Long-term efficacy and safety of botulinum toxin type A (Dysport) in . . .
The aim of this study was to evaluate the efficacy and safety of intramuscular (IM) administration of botulinum toxin type A (Dysport ®, Ipsen Biopharm Ltd ) for the treatment of cervical dystonia (CD) and the long-term safety and efficacy of repeated treatments
|
|